Atlas Trials

Non-small Cell Lung Cancer Recurrent

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-small Cell Lung Cancer Recurrent

RecordFirmDate
Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male Subjects (NCT05110118)Shandong Boan Biotechnology Co., Ltd2020-08-04
ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer (NCT03445000)ETOP IBCSG Partners Foundation2018-11-06
Cancer Panel From Blood of Lung Cancer Patients (NCT03235765)Seoul National University Hospital2017-03-10
A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer (NCT02967133)Alliance Foundation Trials, LLC.2016-12-01
Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer (NCT02460367)NewLink Genetics Corporation2016-01-01
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma (NCT02423343)Eli Lilly and Company2015-01-01
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer (NCT01774578)NewLink Genetics Corporation2013-02-01
Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer (NCT01471964)Fox Chase Cancer Center2011-10-20
A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response (NCT01523340)Chonnam National University Hospital2011-09-01

Track Non-small Cell Lung Cancer Recurrent automatically

Every clearance here is in the API, with alerts when new ones post.